NCT00710619 - Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors

Interventions

DRUG

activated recombinant human factor VII

This is an observation of how patients/caregivers dose bypassing agents at home for haemophilia with inhibitors

DRUG

Feiba VH

This is an observation of how patients/caregivers dose bypassing agents at home for hemophilia with inhibitors

Trial Locations (1)

Novo Nordisk Investigational Site, Plainsboro